Collegium Pharmaceutical (COLL) Goodwill (2022 - 2026)

Collegium Pharmaceutical's Goodwill history runs 5 years deep, the most recent figure standing at $145.9 million for Q1 2026.

• In Q1 2026, Goodwill fell 3.21% year-over-year to $145.9 million; the TTM figure through Mar 2026 stood at $145.9 million (down 3.21% YoY), while the FY2025 annual figure was $145.9 million, down 10.11% from the prior year.
• Goodwill was $145.9 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $145.9 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $162.3 million in Q4 2024 to a low of $130.1 million in Q2 2022.
• Historically, Goodwill has averaged $139.6 million across 5 years, with a median of $133.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Goodwill rose 21.27% in 2024, then declined 10.11% in 2025.
• A 5-year view of Goodwill shows it stood at $133.7 million in 2022, then increased by 0.12% to $133.9 million in 2023, then rose by 21.27% to $162.3 million in 2024, then declined by 10.11% to $145.9 million in 2025, then changed by 0.0% to $145.9 million in 2026.
• The last three Goodwill figures came in at $145.9 million (Q1 2026), $145.9 million (Q4 2025), and $145.9 million (Q3 2025), per Business Quant data.